Your browser doesn't support javascript.
loading
DOT1L inhibition does not modify the sensitivity of cutaneous T cell lymphoma to pan-HDAC inhibitors in vitro.
Kwesi-Maliepaard, Eliza Mari; Malik, Muddassir; van Welsem, Tibor; van Doorn, Remco; Vermeer, Maarten H; Vlaming, Hanneke; Jacobs, Heinz; van Leeuwen, Fred.
Afiliación
  • Kwesi-Maliepaard EM; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Malik M; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • van Welsem T; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • van Doorn R; Department of Dermatology, Leiden University Medical Center, Leiden, Netherlands.
  • Vermeer MH; Department of Dermatology, Leiden University Medical Center, Leiden, Netherlands.
  • Vlaming H; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Jacobs H; Division of Tumor Biology and Immunology, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • van Leeuwen F; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, Netherlands.
Front Genet ; 13: 1032958, 2022.
Article en En | MEDLINE | ID: mdl-36425063

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Front Genet Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Front Genet Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Suiza